Login
Navigate Fool.com
Will IRIS beat
the market?
Community Rating: 3 Stars: Appealing

0.00 0.00 (0.00%)

Quote as of

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open 0.00
Previous Close 0.00
Daily Range 0.00 - 0.00
52-Week Range 0.00 - 0.00
Market Cap 0.0000
P/E Ratio 0.00
Dividend (Yield) 0.00 (0.0%)
Volume 0
Average Daily Volume 0
Current FY EPS 0.33

How do you think IRIS
will perform against the market?

Top IRIS Bull/Bear Pitches

 

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches here!

 

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary Rss Feed

5 of Last Week's Biggest Winners

These stocks made longs a lot of money last week.

Danaher 3rd-Quarter Net Up 4.8% on Lower Costs, But Revenue Down

Law Office of Brodsky & Smith, LLC Announces Investigation of IRIS International, Inc.

WeissLaw LLP Investigates IRIS International, Inc.

SHAREHOLDER ALERT: Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches

IRIS International Merger Alert: Briscoe Law Firm and Powers Taylor, LLP Investigate Sale to Danaher

Ryan & Maniskas, LLP Announces Investigation of IRIS International Inc.

Rigrodsky & Long, P.A. Announces Investigation Of IRIS International, Inc. Buyout

24/7 Wall St. Closing Bell — September 17, 2012: Markets Run Out of Steam (NFLX, TSLA, UA, WFC, X, L

24/7 Wall St. Closing Bell — September 17, 2012: Markets Run Out of Steam (NFLX, TSLA, UA, WFC, X, LDK, CCL, FDX, SHOSR, IRIS, THLD, JAZZ)

The Nasdaq Now: Netflix Dips on 'Underperform' Rating

Iris International and Renewable Energy are up in midday trading.

See More IRIS News...

Sector

Technology

Industry

Electronics

IRIS International, Inc. (IRIS) Description

The Company is engaged in the designing, manufacturing and marketing of in vitro diagnostics systems, consumables, and supplies for urinalysis and body fluids testing. Website:

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks